$ONXX Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading in ONYX PHARMACEUTICALS INC.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview


Overview of all insider trading transactions in ONYX PHARMACEUTICALS INC. Get notifications about new insider transactions in ONYX PHARMACEUTICALS INC for free.

Page:   < prev 1 ... 2 3 4 5 6 7 8 9 ... 12 next >

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Aug 08 2012ONXXONYX PHARMACEUTICA ...SHEMA SUZANNE MEVP, General Counse ...Option ExerciseM30.2865619,86413,125
Aug 08 2012ONXXONYX PHARMACEUTICA ...SHEMA SUZANNE MEVP, General Counse ...SellS71.9714,9331,074,72844,11859.1 K to 44.1 K (-25.29 %)
Aug 08 2012ONXXONYX PHARMACEUTICA ...SHEMA SUZANNE MEVP, General Counse ...SellS71.792,000143,58059,05161.1 K to 59.1 K (-3.28 %)
Aug 08 2012ONXXONYX PHARMACEUTICA ...SHEMA SUZANNE MEVP, General Counse ...BuyM35.1812,833451,46561,05148.2 K to 61.1 K (+26.61 %)
Aug 08 2012ONXXONYX PHARMACEUTICA ...SHEMA SUZANNE MEVP, General Counse ...BuyM37.682,10079,12848,21846.1 K to 48.2 K (+4.55 %)
Aug 08 2012ONXXONYX PHARMACEUTICA ...SHEMA SUZANNE MEVP, General Counse ...BuyM32.071,34443,10246,11844.8 K to 46.1 K (+3.00 %)
Aug 08 2012ONXXONYX PHARMACEUTICA ...SHEMA SUZANNE MEVP, General Counse ...BuyM30.2865619,86444,77444.1 K to 44.8 K (+1.49 %)
Aug 08 2012ONXXONYX PHARMACEUTICA ...SHEMA SUZANNE MEVP, General Counse ...SellS71.936,550471,14644,11850.7 K to 44.1 K (-12.93 %)
Aug 08 2012ONXXONYX PHARMACEUTICA ...Torley HelenEVP & Chief Commerc ...SellS71.892,000143,78058,70160.7 K to 58.7 K (-3.29 %)
Aug 03 2012ONXXONYX PHARMACEUTICA ...WIERENGA WENDALLDirectorSellS74.7625018,6909,5809.8 K to 9.6 K (-2.54 %)
Aug 03 2012ONXXONYX PHARMACEUTICA ...COLES N ANTHONYPresident & CEOSellS74.378,820655,943154,033162.9 K to 154 K (-5.42 %)
Jul 27 2012ONXXONYX PHARMACEUTICA ...SHEMA SUZANNE MEVP, General Counse ...SellS73.972,971219,77050,66853.6 K to 50.7 K (-5.54 %)
Jul 27 2012ONXXONYX PHARMACEUTICA ...LOVE TED WEVP, R&D and Tech. ...SellS73.975,241387,68777,75683 K to 77.8 K (-6.31 %)
Jul 27 2012ONXXONYX PHARMACEUTICA ...Torley HelenChief Opertaing Off ...SellS73.974,549336,49860,70165.3 K to 60.7 K (-6.97 %)
Jul 27 2012ONXXONYX PHARMACEUTICA ...WOOD JULIANNA RVP, Public AffairsSellS73.971,495110,58922,21923.7 K to 22.2 K (-6.30 %)
Jul 27 2012ONXXONYX PHARMACEUTICA ...Lasowski JuergenEVP, Corporate Deve ...SellS73.975,348395,60148,96854.3 K to 49 K (-9.85 %)
Jul 27 2012ONXXONYX PHARMACEUTICA ...COLES N ANTHONYPresident & CEOSellS73.9711,883879,007162,853174.7 K to 162.9 K (-6.80 %)
Jul 27 2012ONXXONYX PHARMACEUTICA ...WIGGANS THOMAS GDirectorOption ExerciseA76.792,000153,5802,000
Jul 27 2012ONXXONYX PHARMACEUTICA ...WIGGANS THOMAS GDirectorGrantA0.001,500010,0658.6 K to 10.1 K (+17.51 %)
Jul 27 2012ONXXONYX PHARMACEUTICA ...Fust Matthew KChief Financial Off ...SellS73.975,207385,17167,92473.1 K to 67.9 K (-7.12 %)
Jul 27 2012ONXXONYX PHARMACEUTICA ...LUNDBERG MAGNUSDirectorOption ExerciseA76.792,000153,5802,000
Jul 27 2012ONXXONYX PHARMACEUTICA ...LUNDBERG MAGNUSDirectorGrantA0.001,500012,11610.6 K to 12.1 K (+14.13 %)
Jul 27 2012ONXXONYX PHARMACEUTICA ...Foster-Cheek Kaye ISVP, Global Human R ...SellS73.972,335172,72443,57445.9 K to 43.6 K (-5.09 %)
Jul 27 2012ONXXONYX PHARMACEUTICA ...WIERENGA WENDALLDirectorOption ExerciseA76.792,000153,5802,000
Jul 27 2012ONXXONYX PHARMACEUTICA ...WIERENGA WENDALLDirectorGrantA0.001,50009,8308.3 K to 9.8 K (+18.01 %)
Jul 27 2012ONXXONYX PHARMACEUTICA ...RINGO WILLIAM RDirectorOption ExerciseA76.792,000153,5802,000
Jul 27 2012ONXXONYX PHARMACEUTICA ...RINGO WILLIAM RDirectorGrantA0.001,50004,9603.5 K to 5 K (+43.35 %)
Jul 27 2012ONXXONYX PHARMACEUTICA ...Nevinny Corinne HDirectorOption ExerciseA76.792,000153,5802,000
Jul 27 2012ONXXONYX PHARMACEUTICA ...Nevinny Corinne HDirectorGrantA0.001,500011,46410 K to 11.5 K (+15.05 %)
Jul 12 2012ONXXONYX PHARMACEUTICA ...WOOD JULIANNA RVP, Public AffairsOption ExerciseM30.281,53146,35910,719
Jul 12 2012ONXXONYX PHARMACEUTICA ...WOOD JULIANNA RVP, Public AffairsOption ExerciseM28.551,32137,7155,561
Jul 12 2012ONXXONYX PHARMACEUTICA ...WOOD JULIANNA RVP, Public AffairsSellS68.012,852193,96523,71426.6 K to 23.7 K (-10.74 %)
Jul 12 2012ONXXONYX PHARMACEUTICA ...WOOD JULIANNA RVP, Public AffairsBuyM30.281,53146,35926,56625 K to 26.6 K (+6.12 %)
Jul 12 2012ONXXONYX PHARMACEUTICA ...WOOD JULIANNA RVP, Public AffairsBuyM28.551,32137,71525,03523.7 K to 25 K (+5.57 %)
Jul 27 2012ONXXONYX PHARMACEUTICA ...GRILLO LOPEZ ANTONIO JDirectorOption ExerciseA76.792,000153,5802,000
Jul 27 2012ONXXONYX PHARMACEUTICA ...GRILLO LOPEZ ANTONIO JDirectorGrantA0.001,500011,76510.3 K to 11.8 K (+14.61 %)
Jul 27 2012ONXXONYX PHARMACEUTICA ...GODDARD PAULDirectorOption ExerciseA76.792,000153,5802,000
Jul 27 2012ONXXONYX PHARMACEUTICA ...GODDARD PAULDirectorGrantA0.001,500012,79011.3 K to 12.8 K (+13.29 %)
Jul 11 2012ONXXONYX PHARMACEUTICA ...SHEMA SUZANNE MEVP, General Counse ...Option ExerciseM30.287,719233,73113,781
Jul 11 2012ONXXONYX PHARMACEUTICA ...SHEMA SUZANNE MEVP, General Counse ...Option ExerciseM32.0716,747537,07630,526
Jul 11 2012ONXXONYX PHARMACEUTICA ...SHEMA SUZANNE MEVP, General Counse ...SellS68.534,265292,28053,63957.9 K to 53.6 K (-7.37 %)
Jul 11 2012ONXXONYX PHARMACEUTICA ...SHEMA SUZANNE MEVP, General Counse ...SellS67.4920,2011,363,36557,90478.1 K to 57.9 K (-25.86 %)
Jul 11 2012ONXXONYX PHARMACEUTICA ...SHEMA SUZANNE MEVP, General Counse ...BuyM30.287,719233,73178,10570.4 K to 78.1 K (+10.97 %)
Jul 11 2012ONXXONYX PHARMACEUTICA ...SHEMA SUZANNE MEVP, General Counse ...BuyM32.0716,747537,07670,38653.6 K to 70.4 K (+31.22 %)
Jul 05 2012ONXXONYX PHARMACEUTICA ...Lasowski JuergenEVP, Corporate Deve ...Option ExerciseM28.5514,000399,70025,375
Jul 05 2012ONXXONYX PHARMACEUTICA ...Lasowski JuergenEVP, Corporate Deve ...SellD67.731,30088,04954,31655.6 K to 54.3 K (-2.34 %)
Jul 05 2012ONXXONYX PHARMACEUTICA ...Lasowski JuergenEVP, Corporate Deve ...SellD66.622,326154,95855,61657.9 K to 55.6 K (-4.01 %)
Jul 05 2012ONXXONYX PHARMACEUTICA ...Lasowski JuergenEVP, Corporate Deve ...SellD67.2414,000941,36057,94271.9 K to 57.9 K (-19.46 %)
Jul 05 2012ONXXONYX PHARMACEUTICA ...Lasowski JuergenEVP, Corporate Deve ...BuyM28.5514,000399,70071,94257.9 K to 71.9 K (+24.16 %)
Jun 26 2012ONXXONYX PHARMACEUTICA ...LUNDBERG MAGNUSDirectorOption ExerciseM12.115,00060,5500
Jun 26 2012ONXXONYX PHARMACEUTICA ...LUNDBERG MAGNUSDirectorSellS65.185,000325,87510,61615.6 K to 10.6 K (-32.02 %)
Jun 26 2012ONXXONYX PHARMACEUTICA ...LUNDBERG MAGNUSDirectorBuyM12.115,00060,55015,61610.6 K to 15.6 K (+47.10 %)
Jun 08 2012ONXXONYX PHARMACEUTICA ...SHEMA SUZANNE MEVP, General Counse ...Option ExerciseM30.2810,000302,80021,500
Jun 08 2012ONXXONYX PHARMACEUTICA ...SHEMA SUZANNE MEVP, General Counse ...Option ExerciseM32.0730,000962,10047,000
Jun 08 2012ONXXONYX PHARMACEUTICA ...SHEMA SUZANNE MEVP, General Counse ...SellS44.4410,000444,35153,63963.6 K to 53.6 K (-15.71 %)
Jun 08 2012ONXXONYX PHARMACEUTICA ...SHEMA SUZANNE MEVP, General Counse ...SellS44.4810,000444,75063,63973.6 K to 63.6 K (-13.58 %)
Jun 08 2012ONXXONYX PHARMACEUTICA ...SHEMA SUZANNE MEVP, General Counse ...SellS44.6110,000446,14673,63983.6 K to 73.6 K (-11.96 %)
Jun 08 2012ONXXONYX PHARMACEUTICA ...SHEMA SUZANNE MEVP, General Counse ...SellS44.584,000178,33483,63987.6 K to 83.6 K (-4.56 %)
Jun 08 2012ONXXONYX PHARMACEUTICA ...SHEMA SUZANNE MEVP, General Counse ...SellS44.603,000133,80087,63990.6 K to 87.6 K (-3.31 %)
Jun 08 2012ONXXONYX PHARMACEUTICA ...SHEMA SUZANNE MEVP, General Counse ...SellS44.573,000133,71090,63993.6 K to 90.6 K (-3.20 %)
Jun 08 2012ONXXONYX PHARMACEUTICA ...SHEMA SUZANNE MEVP, General Counse ...BuyM30.2810,000302,80093,63983.6 K to 93.6 K (+11.96 %)
Jun 08 2012ONXXONYX PHARMACEUTICA ...SHEMA SUZANNE MEVP, General Counse ...BuyM32.0730,000962,10083,63953.6 K to 83.6 K (+55.93 %)
Jun 01 2012ONXXONYX PHARMACEUTICA ...OSBORN JOHN ESVP, Global Corpora ...Option ExerciseA44.9387,3603,925,08587,360
Jun 01 2012ONXXONYX PHARMACEUTICA ...OSBORN JOHN ESVP, Global Corpora ...GrantA0.0011,000011,0000 to 11 K
May 18 2012ONXXONYX PHARMACEUTICA ...WIGGANS THOMAS GDirectorGiftG0.001,75008,56510.3 K to 8.6 K (-16.97 %)
May 03 2012ONXXONYX PHARMACEUTICA ...WIERENGA WENDALLDirectorSellS45.4725011,3688,3308.6 K to 8.3 K (-2.91 %)
Apr 27 2012ONXXONYX PHARMACEUTICA ...WOOD JULIANNA RVP, Public AffairsOption ExerciseM30.283,06392,74812,250
Apr 27 2012ONXXONYX PHARMACEUTICA ...WOOD JULIANNA RVP, Public AffairsOption ExerciseM28.552,96284,5656,882
Apr 27 2012ONXXONYX PHARMACEUTICA ...WOOD JULIANNA RVP, Public AffairsOption ExerciseM29.034,374126,9770
Apr 27 2012ONXXONYX PHARMACEUTICA ...WOOD JULIANNA RVP, Public AffairsSellS45.0010,399467,95523,71434.1 K to 23.7 K (-30.48 %)
Apr 27 2012ONXXONYX PHARMACEUTICA ...WOOD JULIANNA RVP, Public AffairsBuyM30.283,06392,74834,11331.1 K to 34.1 K (+9.86 %)
Apr 27 2012ONXXONYX PHARMACEUTICA ...WOOD JULIANNA RVP, Public AffairsBuyM28.552,96284,56531,05028.1 K to 31.1 K (+10.55 %)
Apr 27 2012ONXXONYX PHARMACEUTICA ...WOOD JULIANNA RVP, Public AffairsBuyM29.034,374126,97728,08823.7 K to 28.1 K (+18.44 %)
Apr 03 2012ONXXONYX PHARMACEUTICA ...WIGGANS THOMAS GDirectorOption ExerciseA37.685,000188,4005,000
Apr 03 2012ONXXONYX PHARMACEUTICA ...WIGGANS THOMAS GDirectorGrantA0.003,000010,3157.3 K to 10.3 K (+41.01 %)
Apr 03 2012ONXXONYX PHARMACEUTICA ...RINGO WILLIAM RDirectorOption ExerciseA37.685,000188,4005,000
Apr 03 2012ONXXONYX PHARMACEUTICA ...RINGO WILLIAM RDirectorGrantA0.003,00003,460460 to 3.5 K (+652.17 %)
Apr 03 2012ONXXONYX PHARMACEUTICA ...WIERENGA WENDALLDirectorOption ExerciseA37.685,000188,4005,000
Apr 03 2012ONXXONYX PHARMACEUTICA ...WIERENGA WENDALLDirectorGrantA0.003,00008,5805.6 K to 8.6 K (+53.76 %)
Apr 03 2012ONXXONYX PHARMACEUTICA ...Nevinny Corinne HDirectorOption ExerciseA37.685,000188,4005,000
Apr 03 2012ONXXONYX PHARMACEUTICA ...Nevinny Corinne HDirectorGrantA0.003,00009,9647 K to 10 K (+43.08 %)
Apr 03 2012ONXXONYX PHARMACEUTICA ...LUNDBERG MAGNUSDirectorOption ExerciseA37.685,000188,4005,000
Apr 03 2012ONXXONYX PHARMACEUTICA ...LUNDBERG MAGNUSDirectorGrantA0.003,000010,6167.6 K to 10.6 K (+39.39 %)
Apr 03 2012ONXXONYX PHARMACEUTICA ...GRILLO LOPEZ ANTONIO JDirectorOption ExerciseA37.685,000188,4005,000
Apr 03 2012ONXXONYX PHARMACEUTICA ...GRILLO LOPEZ ANTONIO JDirectorGrantA0.003,000010,2657.3 K to 10.3 K (+41.29 %)
Apr 03 2012ONXXONYX PHARMACEUTICA ...GODDARD PAULDirectorOption ExerciseA37.685,000188,4005,000
Apr 03 2012ONXXONYX PHARMACEUTICA ...GODDARD PAULDirectorGrantA0.003,000011,2908.3 K to 11.3 K (+36.19 %)
Apr 03 2012ONXXONYX PHARMACEUTICA ...WOOD JULIANNA RVP, Public AffairsOption ExerciseA37.6823,000866,64023,000
Apr 03 2012ONXXONYX PHARMACEUTICA ...WOOD JULIANNA RVP, Public AffairsSellD36.5744216,16623,71424.2 K to 23.7 K (-1.83 %)
Apr 03 2012ONXXONYX PHARMACEUTICA ...WOOD JULIANNA RVP, Public AffairsSellD36.5847417,33724,15624.6 K to 24.2 K (-1.92 %)
Apr 03 2012ONXXONYX PHARMACEUTICA ...WOOD JULIANNA RVP, Public AffairsSellD36.5831711,59524,63024.9 K to 24.6 K (-1.27 %)
Apr 03 2012ONXXONYX PHARMACEUTICA ...WOOD JULIANNA RVP, Public AffairsGrantA0.004,050024,94720.9 K to 24.9 K (+19.38 %)
Apr 03 2012ONXXONYX PHARMACEUTICA ...WOOD JULIANNA RVP, Public AffairsGrantA0.004,500020,89716.4 K to 20.9 K (+27.44 %)
Apr 03 2012ONXXONYX PHARMACEUTICA ...Foster-Cheek Kaye ISVP, Global Human R ...Option ExerciseA37.6838,2001,439,37638,200
Apr 03 2012ONXXONYX PHARMACEUTICA ...Foster-Cheek Kaye ISVP, Global Human R ...SellD36.5850518,47145,90946.4 K to 45.9 K (-1.09 %)
Apr 03 2012ONXXONYX PHARMACEUTICA ...Foster-Cheek Kaye ISVP, Global Human R ...GrantA0.0011,000046,41435.4 K to 46.4 K (+31.06 %)
Apr 03 2012ONXXONYX PHARMACEUTICA ...Foster-Cheek Kaye ISVP, Global Human R ...GrantA0.007,500035,41427.9 K to 35.4 K (+26.87 %)
Apr 03 2012ONXXONYX PHARMACEUTICA ...SHEMA SUZANNE MSVP, General Counse ...Option ExerciseA37.6828,0001,055,04028,000
Apr 03 2012ONXXONYX PHARMACEUTICA ...SHEMA SUZANNE MSVP, General Counse ...Option ExerciseA37.6838,2001,439,37638,200
Apr 03 2012ONXXONYX PHARMACEUTICA ...SHEMA SUZANNE MSVP, General Counse ...SellD36.5869425,38553,63954.3 K to 53.6 K (-1.28 %)
Apr 03 2012ONXXONYX PHARMACEUTICA ...SHEMA SUZANNE MSVP, General Counse ...SellD36.5856820,77654,33354.9 K to 54.3 K (-1.03 %)
Apr 03 2012ONXXONYX PHARMACEUTICA ...SHEMA SUZANNE MSVP, General Counse ...GrantA0.0017,150054,90137.8 K to 54.9 K (+45.43 %)
Apr 03 2012ONXXONYX PHARMACEUTICA ...SHEMA SUZANNE MSVP, General Counse ...GrantA0.007,500037,75130.3 K to 37.8 K (+24.79 %)
Apr 03 2012ONXXONYX PHARMACEUTICA ...LOVE TED WEVP, R&D and Tech. ...Option ExerciseA37.6849,7001,872,69649,700
Apr 03 2012ONXXONYX PHARMACEUTICA ...LOVE TED WEVP, R&D and Tech. ...SellD36.5875727,68982,99783.8 K to 83 K (-0.90 %)
Apr 03 2012ONXXONYX PHARMACEUTICA ...LOVE TED WEVP, R&D and Tech. ...GrantA0.0017,150083,75466.6 K to 83.8 K (+25.75 %)
Apr 03 2012ONXXONYX PHARMACEUTICA ...LOVE TED WEVP, R&D and Tech. ...GrantA0.009,800066,60456.8 K to 66.6 K (+17.25 %)
Apr 03 2012ONXXONYX PHARMACEUTICA ...Torley HelenChief Opertaing Off ...Option ExerciseA37.6818,300689,54418,300
Apr 03 2012ONXXONYX PHARMACEUTICA ...Torley HelenChief Opertaing Off ...GrantA0.0017,150065,25048.1 K to 65.3 K (+35.65 %)
Apr 03 2012ONXXONYX PHARMACEUTICA ...Torley HelenChief Opertaing Off ...GrantA0.003,600048,10044.5 K to 48.1 K (+8.09 %)
Apr 03 2012ONXXONYX PHARMACEUTICA ...Lasowski JuergenEVP, Corporate Deve ...Option ExerciseA37.6845,9001,729,51245,900
Apr 03 2012ONXXONYX PHARMACEUTICA ...Lasowski JuergenEVP, Corporate Deve ...SellD36.5875727,68957,94258.7 K to 57.9 K (-1.29 %)
Apr 03 2012ONXXONYX PHARMACEUTICA ...Lasowski JuergenEVP, Corporate Deve ...SellD36.5869425,38458,69959.4 K to 58.7 K (-1.17 %)
Apr 03 2012ONXXONYX PHARMACEUTICA ...Lasowski JuergenEVP, Corporate Deve ...SellD36.5875727,68859,39360.2 K to 59.4 K (-1.26 %)
Apr 03 2012ONXXONYX PHARMACEUTICA ...Lasowski JuergenEVP, Corporate Deve ...GrantA0.0017,150060,15043 K to 60.2 K (+39.88 %)
Apr 03 2012ONXXONYX PHARMACEUTICA ...Lasowski JuergenEVP, Corporate Deve ...GrantA0.009,000043,00034 K to 43 K (+26.47 %)
Apr 03 2012ONXXONYX PHARMACEUTICA ...Fust Matthew KChief Financial Off ...Option ExerciseA37.6845,9001,729,51245,900
Apr 03 2012ONXXONYX PHARMACEUTICA ...Fust Matthew KChief Financial Off ...SellD36.5882029,99372,81073.6 K to 72.8 K (-1.11 %)
Apr 03 2012ONXXONYX PHARMACEUTICA ...Fust Matthew KChief Financial Off ...SellD36.5875727,68873,63074.4 K to 73.6 K (-1.02 %)
Apr 03 2012ONXXONYX PHARMACEUTICA ...Fust Matthew KChief Financial Off ...GrantA0.0017,150074,38757.2 K to 74.4 K (+29.96 %)
Apr 03 2012ONXXONYX PHARMACEUTICA ...Fust Matthew KChief Financial Off ...GrantA0.009,000057,23748.2 K to 57.2 K (+18.66 %)
Apr 03 2012ONXXONYX PHARMACEUTICA ...COLES N ANTHONYPresident & CEOOption ExerciseA37.68142,6005,373,168142,600
Apr 03 2012ONXXONYX PHARMACEUTICA ...COLES N ANTHONYPresident & CEOSellD36.582,40688,007174,330176.7 K to 174.3 K (-1.36 %)
Apr 03 2012ONXXONYX PHARMACEUTICA ...COLES N ANTHONYPresident & CEOSellD36.583,368123,192176,736180.1 K to 176.7 K (-1.87 %)
Apr 03 2012ONXXONYX PHARMACEUTICA ...COLES N ANTHONYPresident & CEOSellD36.582,40688,004180,104182.5 K to 180.1 K (-1.32 %)
Apr 03 2012ONXXONYX PHARMACEUTICA ...COLES N ANTHONYPresident & CEOGrantA0.0060,1000182,510122.4 K to 182.5 K (+49.10 %)
Apr 03 2012ONXXONYX PHARMACEUTICA ...COLES N ANTHONYPresident & CEOGrantA0.0028,0000122,41094.4 K to 122.4 K (+29.66 %)
Mar 06 2012ONXXONYX PHARMACEUTICA ...Fust Matthew KChief Financial Off ...SellS37.5259222,21248,23748.8 K to 48.2 K (-1.21 %)
Feb 16 2012ONXXONYX PHARMACEUTICA ...Fust Matthew KChief Financial Off ...Option ExerciseD34.485,000172,40089,500
Feb 16 2012ONXXONYX PHARMACEUTICA ...Fust Matthew KChief Financial Off ...BuyM34.485,000172,40048,82943.8 K to 48.8 K (+11.41 %)
Feb 03 2012ONXXONYX PHARMACEUTICA ...LOVE TED WEVP, R&D and Tech. ...Payment of ExerciseF41.982,09888,07456,80458.9 K to 56.8 K (-3.56 %)
Feb 03 2012ONXXONYX PHARMACEUTICA ...WIERENGA WENDALLDirectorSellS41.3825010,3455,5805.8 K to 5.6 K (-4.29 %)
Jan 10 2012ONXXONYX PHARMACEUTICA ...Fust Matthew KChief Financial Off ...SellS43.461,78977,75043,82945.6 K to 43.8 K (-3.92 %)
Jan 05 2012ONXXONYX PHARMACEUTICA ...Lasowski JuergenEVP, Corporate Deve ...SellS42.641,23252,53234,00035.2 K to 34 K (-3.50 %)
Dec 09 2011ONXXONYX PHARMACEUTICA ...WIGGANS THOMAS GDirectorGiftG0.001,80007,3159.1 K to 7.3 K (-19.75 %)
Dec 07 2011ONXXONYX PHARMACEUTICA ...Foster-Cheek Kaye ISVP, Global Human R ...Option ExerciseM26.3826,500699,07064,500
Dec 07 2011ONXXONYX PHARMACEUTICA ...Foster-Cheek Kaye ISVP, Global Human R ...SellS43.5629,5001,284,90227,91457.4 K to 27.9 K (-51.38 %)
Dec 07 2011ONXXONYX PHARMACEUTICA ...Foster-Cheek Kaye ISVP, Global Human R ...BuyM26.3826,500699,07057,41430.9 K to 57.4 K (+85.72 %)
Nov 29 2011ONXXONYX PHARMACEUTICA ...WOOD JULIANNA RVP, Public AffairsOption ExerciseM30.289,187278,18215,313
Nov 29 2011ONXXONYX PHARMACEUTICA ...WOOD JULIANNA RVP, Public AffairsOption ExerciseM28.5516,406468,3919,844
Nov 29 2011ONXXONYX PHARMACEUTICA ...WOOD JULIANNA RVP, Public AffairsOption ExerciseM29.0330,626889,0734,374
Nov 29 2011ONXXONYX PHARMACEUTICA ...WOOD JULIANNA RVP, Public AffairsOption ExerciseM24.8435,000869,4000
Nov 29 2011ONXXONYX PHARMACEUTICA ...WOOD JULIANNA RVP, Public AffairsOption ExerciseM28.6215,834453,1690
Nov 29 2011ONXXONYX PHARMACEUTICA ...WOOD JULIANNA RVP, Public AffairsSellS45.00107,0534,817,38516,397123.5 K to 16.4 K (-86.72 %)
Nov 29 2011ONXXONYX PHARMACEUTICA ...WOOD JULIANNA RVP, Public AffairsBuyM30.289,187278,182123,450114.3 K to 123.5 K (+8.04 %)
Nov 29 2011ONXXONYX PHARMACEUTICA ...WOOD JULIANNA RVP, Public AffairsBuyM28.5516,406468,391114,26397.9 K to 114.3 K (+16.77 %)
Nov 29 2011ONXXONYX PHARMACEUTICA ...WOOD JULIANNA RVP, Public AffairsBuyM29.0330,626889,07397,85767.2 K to 97.9 K (+45.55 %)
Nov 29 2011ONXXONYX PHARMACEUTICA ...WOOD JULIANNA RVP, Public AffairsBuyM24.8435,000869,40067,23132.2 K to 67.2 K (+108.59 %)
Nov 29 2011ONXXONYX PHARMACEUTICA ...WOOD JULIANNA RVP, Public AffairsBuyM28.6215,834453,16932,23116.4 K to 32.2 K (+96.57 %)
Nov 21 2011ONXXONYX PHARMACEUTICA ...Fust Matthew KChief Financial Off ...SellS38.0586732,98945,31046.2 K to 45.3 K (-1.88 %)

Page:   < prev 1 ... 2 3 4 5 6 7 8 9 ... 12 next >

Contact us | Follow us on Twitter